• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

丹麦先天性静止性夜盲症患者的遗传和临床特征。

Genetic and Clinical Characterization of Danish Achromatopsia Patients.

机构信息

Department of Ophthalmology, Copenhagen University Hospital-Rigshospitalet, 2600 Glostrup, Denmark.

Department of Clinical Genetics, Copenhagen University Hospital-Rigshospitalet, 2100 Copenhagen, Denmark.

出版信息

Genes (Basel). 2023 Mar 10;14(3):690. doi: 10.3390/genes14030690.

DOI:10.3390/genes14030690
PMID:36980963
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10048638/
Abstract

Achromatopsia is a rare congenital condition with cone photoreceptor dysfunction causing color blindness, reduced vision, nystagmus and photophobia. New treatments are being developed, but the current evidence is still conflicting regarding possible progression over time, and there is no clear genotype-phenotype correlation. This natural history study aimed to further explore the course of disease and potential clinical differences between various genotypes. The retrospective design allowed for the study of a large cohort with a long follow-up. Patients were identified from the Danish national registries. If not already available, genetic analysis was offered to the patient. Clinical data from 1945-2022 were retrieved from medical records and included best-corrected visual acuity (BCVA), color vision, refractive error, nystagmus, visual fields and fundoscopic findings. We identified variants believed to be disease causing in five of the known achromatopsia genes: ; ; ; and ; and novel variants were identified in and . Progressive deterioration of BCVA only attributable to achromatopsia was found in three of 58 patients. Progressive phenotype was seen with variants in and The results indicate that myopia could be more frequently occurring with variants in , and and support the evidence that achromatopsia is a predominantly stationary condition with respect to BCVA. Although a clear genotype-phenotype correlation can still not be concluded, there may be differences in phenotypical characteristics with variants in different genes.

摘要

全色盲是一种罕见的先天性疾病,由于视锥细胞功能障碍导致色盲、视力下降、眼球震颤和畏光。新的治疗方法正在开发中,但目前关于疾病随时间进展的可能性的证据仍然存在冲突,并且没有明确的基因型-表型相关性。这项自然史研究旨在进一步探讨疾病的过程和各种基因型之间可能存在的临床差异。回顾性设计允许对大量具有长期随访的患者进行研究。患者是从丹麦国家登记册中确定的。如果尚未进行基因分析,则向患者提供基因分析。从病历中检索了 1945 年至 2022 年的临床数据,包括最佳矫正视力 (BCVA)、色觉、屈光不正、眼球震颤、视野和眼底检查结果。我们在五个已知的全色盲基因中鉴定出了被认为是致病的变异体: ; ; ; 和 ;,并在 和 中发现了新的变异体。在 58 名患者中,有 3 名患者仅归因于全色盲的 BCVA 逐渐恶化。在 和 中发现了进行性表型。结果表明,在 、 和 中,近视可能更常与变异体相关,并且支持全色盲在 BCVA 方面主要是静止状态的证据。尽管仍然无法得出明确的基因型-表型相关性,但不同基因的变异体可能存在表型特征的差异。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ce9/10048638/f22906f45f29/genes-14-00690-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ce9/10048638/f0a23c8aeedb/genes-14-00690-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ce9/10048638/ce161b6ae167/genes-14-00690-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ce9/10048638/f8c90ecefa61/genes-14-00690-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ce9/10048638/4e54abb2a5c1/genes-14-00690-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ce9/10048638/f22906f45f29/genes-14-00690-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ce9/10048638/f0a23c8aeedb/genes-14-00690-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ce9/10048638/ce161b6ae167/genes-14-00690-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ce9/10048638/f8c90ecefa61/genes-14-00690-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ce9/10048638/4e54abb2a5c1/genes-14-00690-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ce9/10048638/f22906f45f29/genes-14-00690-g005.jpg

相似文献

1
Genetic and Clinical Characterization of Danish Achromatopsia Patients.丹麦先天性静止性夜盲症患者的遗传和临床特征。
Genes (Basel). 2023 Mar 10;14(3):690. doi: 10.3390/genes14030690.
2
Molecular and Clinical Characterization of and Genes in Brazilian Patients Affected with Achromatopsia.巴西色盲症患者的 和 基因的分子和临床特征。
Genes (Basel). 2023 Jun 20;14(6):1296. doi: 10.3390/genes14061296.
3
Phenotypic characteristics of Danish patients with achromatopsia.丹麦色盲症患者的表型特征。
Acta Ophthalmol. 2024 Sep;102(6):e893-e905. doi: 10.1111/aos.16656. Epub 2024 Feb 13.
4
Molecular and clinical characterization of Thai patients with achromatopsia: identification of three novel disease-associated variants in the CNGA3 and CNGB3 genes.泰国先天性静止性夜盲症患者的分子和临床特征:在 CNGA3 和 CNGB3 基因中鉴定出三个新的疾病相关变异体。
Int Ophthalmol. 2021 Jan;41(1):121-134. doi: 10.1007/s10792-020-01559-2. Epub 2020 Aug 31.
5
Gene Therapy for Achromatopsia.基因治疗色盲症。
Int J Mol Sci. 2024 Sep 9;25(17):9739. doi: 10.3390/ijms25179739.
6
CNGB3 mutation spectrum including copy number variations in 552 achromatopsia patients.552 名色盲症患者的 CNGB3 突变谱,包括拷贝数变异。
Hum Mutat. 2017 Nov;38(11):1579-1591. doi: 10.1002/humu.23311. Epub 2017 Aug 28.
7
Clinical and Genetic Features of Korean Patients with Achromatopsia.韩国色盲症患者的临床和遗传特征。
Genes (Basel). 2023 Feb 18;14(2):519. doi: 10.3390/genes14020519.
8
Novel mutations in the gene for α-subunit of retinal cone cyclic nucleotide-gated channels in a Japanese patient with congenital achromatopsia.一名患有先天性全色盲的日本患者视网膜视锥细胞环核苷酸门控通道α亚基基因的新突变。
Jpn J Ophthalmol. 2016 May;60(3):187-97. doi: 10.1007/s10384-016-0424-6. Epub 2016 Feb 5.
9
Achromatopsia全色盲
10
Comprehensive variant spectrum of the CNGA3 gene in patients affected by achromatopsia.CNGA3 基因变异谱与全色盲患者的相关性研究。
Hum Mutat. 2022 Jul;43(7):832-858. doi: 10.1002/humu.24371. Epub 2022 Apr 14.

引用本文的文献

1
Expanding the genetic spectrum of achromatopsia: novel CNGA3 and CNGB3 variants.扩大全色盲的基因谱:新型CNGA3和CNGB3变体
Int Ophthalmol. 2025 Jul 23;45(1):313. doi: 10.1007/s10792-025-03650-y.
2
Molecular Mechanisms Governing Sight Loss in Inherited Cone Disorders.遗传性锥细胞疾病致盲的分子机制。
Genes (Basel). 2024 Jun 1;15(6):727. doi: 10.3390/genes15060727.
3
[Achromatopsia : Clinical aspects, diagnostics, genes, brain and quality of life].[全色盲:临床方面、诊断、基因、大脑与生活质量]

本文引用的文献

1
Comprehensive variant spectrum of the CNGA3 gene in patients affected by achromatopsia.CNGA3 基因变异谱与全色盲患者的相关性研究。
Hum Mutat. 2022 Jul;43(7):832-858. doi: 10.1002/humu.24371. Epub 2022 Apr 14.
2
ATF6 is essential for human cone photoreceptor development.ATF6 对于人类视锥细胞的发育是必需的。
Proc Natl Acad Sci U S A. 2021 Sep 28;118(39). doi: 10.1073/pnas.2103196118.
3
Disease Progression in and Retinopathy; Characteristics of Slovenian Cohort and Proposed OCT Staging Based on Pooled Data from 126 Patients from 7 Studies.
Ophthalmologie. 2023 Sep;120(9):975-986. doi: 10.1007/s00347-023-01904-7. Epub 2023 Aug 28.
4
Morphological and Functional Aspects and Quality of Life in Patients with Achromatopsia.全色盲患者的形态学、功能学方面及生活质量
J Pers Med. 2023 Jul 7;13(7):1106. doi: 10.3390/jpm13071106.
与视网膜病变的疾病进展;基于来自 7 项研究的 126 名患者的汇总数据提出的斯洛文尼亚队列的特征和 OCT 分期。
Curr Issues Mol Biol. 2021 Aug 16;43(2):941-957. doi: 10.3390/cimb43020067.
4
Three-year results of phase I retinal gene therapy trial for CNGA3-mutated achromatopsia: results of a non randomised controlled trial.CNGA3 突变性无色素性视网膜炎的 I 期视网膜基因治疗试验的 3 年结果:一项非随机对照试验的结果。
Br J Ophthalmol. 2022 Nov;106(11):1567-1572. doi: 10.1136/bjophthalmol-2021-319067. Epub 2021 May 18.
5
Clinical and Molecular Characterization of Achromatopsia Patients: A Longitudinal Study.全色盲患者的临床与分子特征:一项纵向研究。
Int J Mol Sci. 2021 Feb 7;22(4):1681. doi: 10.3390/ijms22041681.
6
Ametropia and Emmetropization in CNGB3 Achromatopsia.CNGB3 型先天性静止性夜盲症的屈光不正和正视化。
Invest Ophthalmol Vis Sci. 2021 Feb 1;62(2):10. doi: 10.1167/iovs.62.2.10.
7
PDE6C: Novel Mutations, Atypical Phenotype, and Differences Among Children and Adults.PDE6C:新突变、非典型表型以及儿童与成人之间的差异。
Invest Ophthalmol Vis Sci. 2020 Oct 1;61(12):1. doi: 10.1167/iovs.61.12.1.
8
Long-Term Investigation of Retinal Function in Patients with Achromatopsia.全色盲患者视网膜功能的长期研究。
Invest Ophthalmol Vis Sci. 2020 Sep 1;61(11):38. doi: 10.1167/iovs.61.11.38.
9
Genotypes and phenotypes of genes associated with achromatopsia: A reference for clinical genetic testing.与色盲相关基因的基因型和表型:临床基因检测参考。
Mol Vis. 2020 Aug 22;26:588-602. eCollection 2020.
10
Safety and Vision Outcomes of Subretinal Gene Therapy Targeting Cone Photoreceptors in Achromatopsia: A Nonrandomized Controlled Trial.针对无色素性视锥细胞营养不良的视网膜下基因治疗的安全性和视觉效果:一项非随机对照试验。
JAMA Ophthalmol. 2020 Jun 1;138(6):643-651. doi: 10.1001/jamaophthalmol.2020.1032.